Real-world data show reduction in use of urate-lowering therapy among people with type 2 diabetes using SGLT2 inhibitors.

According to the World Health Organisation (WHO), over 350 million people globally suffer from arthritis, and despite ...

Discover the causes, symptoms, and treatment options for gout—a painful form of arthritis predominantly affecting men.

Substantial improvements in ultrasound technology and expanded use of it have necessitated an update of the 2012 ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good morning, ladies and gentlemen, and welcome to the Protalix ...

Amgen today announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of Rheumatology (ACR) Convergence 2024 conference in Washington, D.C., ...